Metrikler
Yayın
6
Açık Erişim
1
Makaleler
Tümü (6)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)
TRDizin (1)
2025
20251. Prognostic value of HER2 2 + expression in patients with TNBC receiving adjuvant capecitabine
Önder T., CENGİZ M., Koçoğlu S. S., Ateş Ö., YAZICI O., İNANÇ M., et al.
Clinical and Translational Oncology
, cilt.27, sa.7, ss.3121-3129, 2025 (SCI-Expanded, Scopus)
2025
20252. The Role of Clinicopathological Features in Tyrosine Kinase Inhibitory Duration in EGFR Mutant Metastatic Non-Small Cell Lung Cancer
Dogan E., Firat S. T., CENGİZ M., BOZKURT O., İNANÇ M., ÖZKAN M.
Journal of Clinical Medicine
, cilt.14, sa.4, 2025 (SCI-Expanded, Scopus)
2025
20253. Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer
BUĞDAY İ., İNANÇ M., ÖZKAN M., BOZKURT O., COŞAR R., FIRAT S. T., et al.
Anti-Cancer Drugs
, cilt.36, 2025 (SCI-Expanded, Scopus)
2025
20254. Impact of Clinicopathological Features on Prognosis in KRAS Mutant Metastatic Colorectal Cancer
Dogan E., CENGİZ M., BOZKURT O., İNANÇ M., ÖZKAN M.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.35, sa.1, ss.12-16, 2025 (SCI-Expanded, Scopus)
2025
20255. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
YILDIRIM H. Ç., Kapar C., KÖKSAL B., Seyyar M., CAN ŞANCI P., GULIYEV M., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.37, sa.1, ss.69-75, 2025 (SCI-Expanded, Scopus)
2024
20246. The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas
MUTLU E., BOZKURT O., İnanç M., Ozkan M., FIRAT S. T., Coşar R., et al.
Hitit medical journal (Online)
, cilt.6, sa.1, ss.71-78, 2024 (TRDizin)
